From: Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
Exercise group | Â |
---|---|
Number of patients | 40 |
Age (years old) | 56.5(39–75) |
Pretreatment CA-125 (U/ml) | 889(153–7561) |
Histology: Serous carcinoma | 40(100%) |
FIGO stage: Advanced | 40(100%) |
Tumor grade: high | 40(100%) |
Debulking surgery | Â |
 R0 | 13(32.5%) |
 R1 | 27(67.5%) |
Platinum response | Â |
 Sensitive | 23(57.5%) |
 Resistant | 17(42.5%) |
Recurrence | Â |
 Yes | 31(77.5%) |
 No | 9(22.5%) |
Death | Â |
 Yes | 21(52.5%) |
 No | 19(47.5%) |